Q
QuantAbundance

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

31,141 signal articles · 170 in last 24h · 159,401 total before filter · latest 41m ago
170last 24h
898last 7d
127● bullish (7d)
88● bearish (7d)
214publishers
AllMacro192Earnings195M&A94Regulatory16Product18Analyst29
✕ clear all filtersSentiment:bullishneutralbearishshow all (incl. clickbait)
Earnings Outlook Brightens as Estimates Keep Rising
Zacks109d agoneutral
Earnings Outlook Brightens as Estimates Keep Rising

The earnings revisions trend for full-year 2026 has been positive for quite some time now, with estimates for 11 of the 16 Zacks sectors increasing since the start of March. Energy, Basic Materials, and Technology have been the biggest beneficiaries.

5-star analyst tweaks Oracle stock price target after earnings
TheStreet109d agoneutral
5-star analyst tweaks Oracle stock price target after earnings

On June 12, Oracle’s (ORCL) earnings beat ran straight into what has apparently been a wall of investor worry. Wall Street had been looking for proof that Oracle’s cloud infrastructure business was still riding the AI boom, and the company delivered plenty of it. Revenue surged, Oracle Cloud ...

Eli Lilly Stock Hits Buy Zone As Earnings Soar 156%. Funds Are Loading Up.
Investor's Business Daily110d agobullish
Eli Lilly Stock Hits Buy Zone As Earnings Soar 156%. Funds Are Loading Up.

With the massive SpaceX debut hogging the headlines, some retail investors may have allowed more prosaic names to slip from their minds. Pharma stock Eli Lilly is trading in a buy zone as institutional investors load up. Eli Lilly is committed to innovation and reinvests 20%-25% of its sales back into developing new treatments.

CVS Health (CVS): Buy, Sell, or Hold Post Q1 Earnings?
StockStory110d agoneutral
CVS Health (CVS): Buy, Sell, or Hold Post Q1 Earnings?

Over the past six months, CVS Health has been a great trade, beating the S&P 500 by 20%. Its stock price has climbed to $100.39, representing a healthy 26.4% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

How To Earn $500 A Month From Jabil Stock Ahead Of Q3 Earnings
Benzinga110d agoneutral
How To Earn $500 A Month From Jabil Stock Ahead Of Q3 Earnings

Jabil Inc.will release earnings for its third quarter before the opening bell on Wednesday, June 17. Analysts expect the Florida-based manufacturer to report quarterly earnings of $3.10 per share. That’s up from $2.55 per share in the year-ago period. The...

Adobe Beats Expectations and Raises Outlook, but Shares Fall on ARR Concerns (ADBE)
InvestorsHub110d agobullish
Adobe Beats Expectations and Raises Outlook, but Shares Fall on ARR Concerns (ADBE)

Adobe (NASDAQ:ADBE) delivered stronger-than-expected second-quarter results on Thursday, surpassing Wall Street forecasts for both revenue and earnings while increasing its full-year guidance. However, the stock moved lower in premarket trading after investors focused on unchanged annual recurring revenue projections and another senior leadership transition.

Adobe Q2 Earnings Call Highlights
MarketBeat110d agoneutral
Adobe Q2 Earnings Call Highlights

Adobe (NASDAQ:ADBE) reported record fiscal second-quarter revenue and raised its full-year revenue outlook, while executives outlined a strategic shift toward more aggressive freemium user acquisition across Acrobat, Express and Firefly that is expected to weigh on second-half annual recurring reven

Cal-Maine (CALM): Buy, Sell, or Hold Post Q1 Earnings?
StockStory111d agoneutral
Cal-Maine (CALM): Buy, Sell, or Hold Post Q1 Earnings?

Over the past six months, Cal-Maine’s stock price fell to $79.32. Shareholders have lost 9.4% of their capital, which is disappointing considering the S&P 500 has climbed by 6.9%. This might have investors contemplating their next move.